Some news from the company website.Change Financial selected for New York Fintech Program
PRESS RELEASEPUBLISHED ON 13 MAY 2022Change was selected in a cohort of 9 Australian fintechs to participate in theFintech AustralianandAustradeprogram to help financial services and technology providers scale in the US market.
Across May and June, the cohort will attend the in-person program in New York where they will promote their offering, meet partners, clients, investors and mentors to build their US market presence. The cohort will also attend theLendit Fintech 2022 Conferenceat the end of May, which includes the Demo Day hosted byWEVE Accelerationand Austrade.
Austrade’s Steve Rank, Trade and Investment Commissioner New York, explained “Australia’s fintech sector will be showcased in New York when 9 of the best and brightest Australian Fintech startups visit in May.”
Change will be presented by Clayton Fossett (COO) and Brian Hodgdon (VP – Business Development and Customer Relations) and promote ourVertexonPayments as a Service andPaySimpayments simulation and testing products.
Change will be joined by
Change is honored to have been selected along with such esteemed fintechs and looks forward to building our presence in the US.
Wonder if CCA is eligible for Austrade grants or funding?
- Forums
- ASX - By Stock
- CCA
- CCA Initiation Report - MST Access
CCA Initiation Report - MST Access, page-8
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCA (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
-0.001(1.33%) |
Mkt cap ! $47.07M |
Open | High | Low | Value | Volume |
7.5¢ | 7.6¢ | 7.4¢ | $103.2K | 1.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 176862 | 0.074 |
2 | 525099 | 0.073 |
4 | 63536 | 0.072 |
2 | 314098 | 0.071 |
3 | 672057 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 100000 | 1 |
0.080 | 47316 | 2 |
0.083 | 9892 | 1 |
0.085 | 20000 | 1 |
0.096 | 150000 | 1 |
Last trade - 15.55pm 15/07/2024 (20 minute delay) ? |
Featured News
CCA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online